• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Janssen’s Tremyfa scores success in Phase III ulcerative colitis trial

Quote
cafead

cafead

Administrator
Staff member
  • cafead   May 10, 2023 at 10:22: AM
via Janssen has released new safety and efficacy data from a Phase III trial investigating Tremyfa (guselkumab) in adults with moderately to severely active ulcerative colitis (UC).

Tremyfa is a fully human immunoglobulin G1 lambda monoclonal antibody (mAb) that binds to the human interleukin (IL)-23 receptor.

article source
 




Top Bottom
Back
Quote